High expression of BASP1 is associated with poor prognosis of human LUAD and head and neck squamous cell carcinoma and promotes tumor progression (Jaikumarr Ram et al., 2020; Wang et al., 2021). Here, BASP1 is linked to head and neck squamous cell carcinoma.